Barely Significant
← all excerpts

Evaluation of rosuvastatin-induced QT prolongation risk using real-world data, in vitro cardiomyocyte studies, and mortality assessment.

Sci Rep · 2023 · PMC10199059 · PMID 37208484

Europe PMCDOI
1
hedged sentence
0.0647
closest p · 1.3× alpha
0.0647
boldest claim

The sentences

marginal significancep = 0.0647so close (0.05 < p ≤ 0.1)
Although these results were not statistically significant due to insufficient patient numbers, QT interval prolongation risk was associated with rosuvastatin use with marginal significance ( p = 0.0647).

also in 3,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.